DEPRESSÃO EM PACIENTES COM DIABETES MELLITUS TIPO 2: UMA REVISÃO NARRATIVA
DOI:
https://doi.org/10.63845/9hr7rc93Palavras-chave:
Diabetes Mellitus tipo 2, Depressão, Transtorno Depressivo, ComorbidadeResumo
A depressão em pessoas com diabetes mellitus tipo 2 (DM2) é muito prevalente e está relacionada a uma maior dificuldade no controle e enfrentamento do diabetes, o que torna fundamental a triagem e o manejo adequado dessa condição. O presente estudo tem por objetivo realizar uma revisão narrativa dos estudos publicados sobre a epidemiologia, fisiopatologia, impacto clínico, metabólico e psicossocial, triagem e tratamento da depressão em pessoas com DM2. Foram observadas altas taxas de comorbidade entre depressão e DM2, com uma relação bidirecional entre as duas condições, explicada por mecanismos biológicos e psicossociais compartilhados. Os fatores associados à maior prevalência de depressão no diabetes foram sexo feminino, menor escolaridade, diagnóstico recente do diabetes, baixa atividade física e uso de insulina. Quanto aos impactos da depressão no DM2, observou-se dificuldade de adesão ao tratamento, pior controle glicêmico, maior risco de complicações e mortalidade, e redução da qualidade de vida. No que tange ao rastreio, a triagem rotineira tem sido recomendada, utilizando ferramentas validadas. Entre os tratamentos, diversas modalidades de intervenção, incluindo abordagens psicossociais e farmacológicas, estão associadas a uma melhora importante dos sintomas depressivos e do controle do diabetes.
Referências
International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021.
Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. São Paulo: Clannad; 2019.
Bădescu S, Tătaru C, Kobylinska L, Georgescu E, Zahiu D, Zăgrean A, et al. The association between Diabetes mellitus and Depression. J Med Life. 2016;9(2):120–5.
Herder C, Hermanns N. Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes. Semin Immunopathol. 2019;41(4):477–89. DOI: https://doi.org/10.1007/s00281-019-00730-x
Zheng K, Abraham C, Bruzzese JM, Smaldone A. Longitudinal Relationships Between Depression and Chronic Illness in Adolescents: An Integrative Review. J Pediatr Health Care. 2020;34(4):333–45. DOI: https://doi.org/10.1016/j.pedhc.2020.01.008
Schmitt A, Reimer A, Hermanns N, Kulzer B, Ehrmann D, Haak T. The effects of depression and subthreshold depression on the 5-year course of glycaemic control and clinical outcomes in type 2 diabetes. Diabetologia. 2016;59(9):1843-51.
American Diabetes Association. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Supplement_1):S60-S82. DOI: https://doi.org/10.2337/dc22-S005
Mukherjee N, Chaturvedi SK. Depressive symptoms and disorders in type 2 diabetes mellitus. Curr Opin Psychiatry. 2019;32(5):416–21. DOI: https://doi.org/10.1097/YCO.0000000000000528
Darwish L, Beroncal E, Sison MaV, Swardfager W. Depression in people with type 2 diabetes: current perspectives. DMSO. 2018;Volume 11:333–43. DOI: https://doi.org/10.2147/DMSO.S106797
Meurs M, Roest AM, Wolffenbuttel BHR, Stolk RP, de Jonge P, Rosmalen JGM. Association of Depressive and Anxiety Disorders With Diagnosed Versus Undiagnosed Diabetes: An Epidemiological Study of 90,686 Participants. Psychosom Med. 2016;78(2):233–41. DOI: https://doi.org/10.1097/PSY.0000000000000255
Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, et al. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med. 2018;35(6):760–9. DOI: https://doi.org/10.1111/dme.13611
Wang Y, Lopez JMS, Bolge SC, Zhu VJ, Stang PE. Depression among people with type 2 diabetes mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005–2012. BMC Psychiatry. 2016;16(1):88. DOI: https://doi.org/10.1186/s12888-016-0800-2
Voinova M, Mansour H, Gadelha A, Cordeiro Q, Gadelha A. The Bidirectional Relationship Between Depression and Type 2 Diabetes Mellitus (T2DM): A Systematic Review. Front. Endocrinol. 2021;12:657599.
Graham EA, Deschênes SS, Khalil MN, Danna S, Filion KB, Schmitz N. Measures of depression and risk of type 2 diabetes: A systematic review and meta-analysis. J Affect Disord. 2020;265:224–32. DOI: https://doi.org/10.1016/j.jad.2020.01.053
Hamer JA, Testani D, Mansur RB, Lee Y, Subramaniapillai M, McIntyre RS. Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression. Exp Neurol. 2019;315:1–8. DOI: https://doi.org/10.1016/j.expneurol.2019.01.016
Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman ATF, Penninx BWJH. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013;18(6):692–9. DOI: https://doi.org/10.1038/mp.2012.144
Varshney P, Parveen R, Khan MA, Kohli S, Agarwal NB. Increased serum interleukin-9 and interleukin-1β are associated with depression in type 2 diabetes patients. Arq Neuro-Psiquiatr. 2020;78:255–61. DOI: https://doi.org/10.1590/0004-282x20190177
Laake JPS, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC, et al. The Association Between Depressive Symptoms and Systemic Inflammation in People With Type 2 Diabetes: Findings From the South London Diabetes Study. Diabetes Care. 2014;37(8):2186–92. DOI: https://doi.org/10.2337/dc13-2522
Liu D, McIntyre RS, Li R, Yang M, Xue Y, Cao B. Genetic association between major depressive disorder and type 2 diabetes mellitus: Shared pathways and protein networks. Prog Neuro-Psychopharmacology Biol Psychiatry. 2021;111:110339. DOI: https://doi.org/10.1016/j.pnpbp.2021.110339
Ji HF, Zhuang QS, Shen L. Genetic overlap between type 2 diabetes and major depressive disorder identified by bioinformatics analysis. Oncotarget. 2016;7(14):17410–4. DOI: https://doi.org/10.18632/oncotarget.8202
Mansyur CL, Rustveld LO, Nash SG, Jibaja-Weiss ML. Psychosocial Contributors to Depressive Symptoms in Hispanic Patients With Type 2 Diabetes. The Science of Diabetes Self-Management and Care. 2021;47(6):415–24. DOI: https://doi.org/10.1177/26350106211054420
Rathmann W, Kuß O, Anderson D, Busch S, Hahn M, Engelhard J, et al. Increased depression symptom score in newly diagnosed type 2 diabetes patients. Psychiatry Res. 2018;261:259–63. DOI: https://doi.org/10.1016/j.psychres.2017.12.091
Yang L, Zhao Y, Wang Y, Liu L, Zhang X, Li B, et al. The Effects of Psychological Stress on Depression. Curr Neuropharmacol. 2015;13(4):494–504. DOI: https://doi.org/10.2174/1570159X1304150831150507
Gonzalez JS, Shmukler C, Safren SA, et al. A randomized controlled trial of a tailored cognitive-behavioral therapy for adherence and depression in patients with type 2 diabetes. J Consult Clin Psychol. 2016;84(1):58-69.
Hoogendoorn CJ, Shapira A, Roy JF, Walker EA, Cohen HW, Gonzalez JS. Depressive symptom dimensions and medication non-adherence in suboptimally controlled type 2 diabetes. J Diabetes Complications. 2019;33(3):217–22. DOI: https://doi.org/10.1016/j.jdiacomp.2018.12.001
Schmitt A, Bendig E, Baumeister H, Hermanns N, Kulzer B. Associations of depression and diabetes distress with self-management behavior and glycemic control. Health Psychol. 2021;40(2):113–24. DOI: https://doi.org/10.1037/hea0001037
Brown SA, García AA, Brown A, Becker BJ, Conn VS, Ramírez G, et al. Biobehavioral determinants of glycemic control in type 2 diabetes: A systematic review and meta-analysis. Patient Educ Couns. 2016;99(10):1558–67. DOI: https://doi.org/10.1016/j.pec.2016.03.020
Guerrero Fernández de Alba I, Gimeno-Miguel A, Poblador-Plou B, Gimeno-Feliu LA, Ioakeim-Skoufa I, Rojo-Martínez G, et al. Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients. Sci Rep. 2020;10(1):19583. DOI: https://doi.org/10.1038/s41598-020-76546-9
Wu CS, Hsu LY, Pan YJ, Wang SH. Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus. J Clin Endocrinol Metab. 2021;106(12):e5136-46. DOI: https://doi.org/10.1210/clinem/dgab443
Chen HM, Yang YH, Chen KJ, Lee Y, McIntyre RS, Lu ML, et al. Antidepressants Reduced Risk of Mortality in Patients With Diabetes Mellitus: A Population-Based Cohort Study in Taiwan. J Clin Endocrinol Metab. 2019;104(10):4619–25. DOI: https://doi.org/10.1210/jc.2018-02362
Wu CS, Hsu LY, Wang SH. Association of depression and diabetes complications and mortality: a population-based cohort study. Epidemiol Psychiatr Sci. 2020;29:e96. DOI: https://doi.org/10.1017/S2045796020000049
Moulton CD, Murray L, Winkley K, Amiel SA, Ismail K, Patel A. Depression and change in occupational functioning in type 2 diabetes. Occup Med (Lond). 2019;69(5):322–8. DOI: https://doi.org/10.1093/occmed/kqz072
Le TK, Able SL, Lage MJ. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression. Cost Eff Resour Alloc. 2006;4(1):18. DOI: https://doi.org/10.1186/1478-7547-4-18
Juárez-Rojop IE, Fortuny-Falconi CM, González-Castro TB, Tovilla-Zárate CA, Villar-Soto M, Sanchez ER, et al. Association between reduced quality of life and depression in patients with type 2 diabetes mellitus: a cohort study in a Mexican population. Neuropsychiatr Dis Treat. 2018;14:2511–8. DOI: https://doi.org/10.2147/NDT.S167622
Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML, Gutierrez-Gonzalez A, Najera-Ahumada AG, Cisneros-González N. Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health Qual Life Outcomes. 2018;16(1):94. DOI: https://doi.org/10.1186/s12955-018-0906-y
Barnacle M, Strand MA, Werremeyer A, Maack B, Petry N. Depression Screening in Diabetes Care to Improve Outcomes: Are We Meeting the Challenge? Diabetes Educ. 2016;42(5):646–51. DOI: https://doi.org/10.1177/0145721716662917
van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR, Brals JW, Vloedbeld MG, Veneman TF, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res. 2010;10(1):235. DOI: https://doi.org/10.1186/1472-6963-10-235
Janssen EPCJ, Köhler S, Stehouwer CDA, Schaper NC, Dagnelie PC, Sep SJS, et al. The Patient Health Questionnaire-9 as a Screening Tool for Depression in Individuals with Type 2 Diabetes Mellitus: The Maastricht Study. J Am Geriatr Soc. 2016;64(11):e201-e206. DOI: https://doi.org/10.1111/jgs.14388
Rauwerda NL, Tovote KA, Peeters ACTM, Sanderman R, Emmelkamp PMG, Schroevers MJ, et al. WHO-5 and BDI-II are acceptable screening instruments for depression in people with diabetes. Diabet Med. 2018;35(12):1678–85. DOI: https://doi.org/10.1111/dme.13779
Halliday JA, Hendrieckx C, Busija L, Browne JL, Nefs G, Pouwer F, et al. Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: Results from Diabetes MILES – Australia. Diabetes Res Clin Pract. 2017;132:27–35. DOI: https://doi.org/10.1016/j.diabres.2017.07.005
van der Feltz-Cornelis C, Allen SF, Holt RIG, Roberts R, Nouwen A, Sartorius N. Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta-analysis. Brain Behav. 2021;11(2):e01981. DOI: https://doi.org/10.1002/brb3.1981
Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, et al. A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes. Diabetes Care. 2014;37(3):625–33. DOI: https://doi.org/10.2337/dc13-0816
Yekta Z, Xie D, Bogner HR, Weber DR, Zhang X, Harhay M, et al. The association of antidepressant medications and diabetic retinopathy among people with diabetes. J Diabetes its Complications. 2015;29(8):1077–84. DOI: https://doi.org/10.1016/j.jdiacomp.2015.06.009
Roopan S, Larsen ER. Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatr. 2017;29(3):127–39. DOI: https://doi.org/10.1017/neu.2016.54
Gehlawat P, Gupta R, Rajput R, Gahlan D, Gehlawat VK. Diabetes with comorbid depression: role of SSRI in better glycemic control. Asian J Psychiatr. 2013;6(5):364–8. DOI: https://doi.org/10.1016/j.ajp.2013.03.007
de Groot M, Shubrook JH, Hornsby WG, Pillay Y, Mather K, Fitzpatrick K, et al. Program ACTIVE II: Outcomes From a Randomized, Multistate Community-Based Depression Treatment for Rural and Urban Adults With Type 2 Diabetes. Diabetes Care. 2019;42(7):1185–93. DOI: https://doi.org/10.2337/dc18-2400
Wroe AL, Rennie EW, Sollesse S, Chapman J, Hassy A. Is Cognitive Behavioural Therapy focusing on Depression and Anxiety Effective for People with Long-Term Physical Health Conditions? A Controlled Trial in the Context of Type 2 Diabetes Mellitus. Behav Cogn Psychother. 2018;46(2):129–47. DOI: https://doi.org/10.1017/S1352465817000492
Uchendu C, Blake H. A systematic review of the psychological and behavioural effects of biking in people with diabetes. Diabet Med. 2017;34(5):611-623.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2026 Revista Científica Arquivos Catarinenses de Medicina
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
